会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Measuring Apparatus, Measuring Coordinate Setting Method and Measuring Coordinate Number Calculation Method
    • 测量装置,测量坐标设定方法和测量坐标数计算方法
    • US20110060552A1
    • 2011-03-10
    • US12839025
    • 2010-07-19
    • Makoto ONO
    • Makoto ONO
    • G06F15/00G01B21/20
    • G01B15/00G01B2210/56H01J2237/24592
    • With little cost and time, this invention makes high-precision measurements over an entire surface of a substrate to check how well devices are fabricated. The devices include integrated circuits, magnetic heads, magnetic discs, solar cells, optical modules, light emitting diodes and liquid crystal display panels—the ones that are fabricated on a substrate by repetitively performing deposition, resist application, exposure, development and etching. The method of this invention involves inputting multipoint measured data and a number of points used for measurement and calculating measuring coordinates by the measuring coordinate calculation program 1161. Next, based on the calculated measuring coordinates, the measuring program 1162 measures device characteristics, such as dimensions of the devices. Next, the curved surface approximation program 1163 calculates approximated values of device characteristics over the entire surface of the substrate, followed by the output program 1164 outputting the approximated values.
    • 本发明的成本和时间都很少,在基板的整个表面上进行高精度测量,以检查器件的制造程度。 这些器件包括集成电路,磁头,磁盘,太阳能电池,光学模块,发光二极管和液晶显示面板 - 通过重复执行沉积,抵抗应用,曝光,显影和蚀刻在衬底上制造的器件。 本发明的方法涉及通过测量坐标计算程序1161输入多点测量数据和用于测量和计算测量坐标的点数。接下来,基于所计算的测量坐标,测量程序1162测量设备特性,例如尺寸 的设备。 接下来,曲面近似程序1163计算衬底的整个表面上的器件特性的近似值,随后输出输出近似值的输出程序1164。
    • 5. 发明申请
    • ACTIVATED BLOOD COAGULATION FACTOR INHIBITOR
    • 活化血液凝血因子抑制剂
    • US20110312991A1
    • 2011-12-22
    • US13181596
    • 2011-07-13
    • Makoto ONO
    • Makoto ONO
    • A61K31/444A61P11/00A61P25/00A61P9/10C07D513/04A61P7/02
    • C07D513/04A61K31/444
    • An object of the present invention is to provide a novel salt form of a compound that exhibits an inhibitory effect on activated blood coagulation factor X, and is useful as a preventive and/or therapeutic drug for thrombotic diseases, and crystals thereof. The present invention provides N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide tartrate and crystals thereof, as a novel salt form of N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide and crystals thereof.
    • 本发明的目的是提供对活化凝血因子X具有抑制作用的化合物的新型盐形式,可用作血栓性疾病的预防和/或治疗药物及其结晶。 本发明提供N1-(5-氯吡啶-2-基)-N2 - ((1S,2R,4S)-4 - [(二甲基氨基)羰基] -2 - {[(5-甲基-4,5,6 ,7-四氢噻唑并[5,4-c]吡啶-2-基)羰基]氨基}环己基)乙二胺酒石酸盐及其晶体,作为N1-(5-氯吡啶-2-基)-N2-( (1S,2R,4S)-4 - [(二甲基氨基)羰基] -2 - {[(5-甲基-4,5,6,7-四氢噻唑并[5,4-c]吡啶-2-基)羰基] 氨基}环己基)乙二胺及其晶体。